Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Taxes (Details) - Schedule of components of company's deferred tax assets and liabilities

v3.22.4
Income Taxes (Details) - Schedule of components of company's deferred tax assets and liabilities - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets    
Tax losses carry forwards $ 678,334 $ 667,741
Inventory related 157 4,210
Intangible assets 11,321 12,783
Provision for employee related obligations 927 1,186
Stock-based compensation 10,242 9,528
Deferred revenue 1,575 2,257
Property, plant and equipment 0 630
Allowance for credit losses 66 143
Foreign currency losses 0 358
Research and development credit carry forwards 17,658 15,933
Research and development capitalization (including Section 174) 11,454 3,717
Gross deferred tax assets 731,734 718,486
Valuation allowance (699,694) (693,120)
Total deferred tax assets 32,040 25,366
Deferred tax liabilities    
Intangibles assets (10,988) (12,533)
Property, plant and equipment (14,652) (17,991)
Basis difference in equity method investment (8,852)
Other items (1,903) (882)
Total deferred tax liabilities (36,395) (31,406)
Net deferred tax assets (liabilities) $ (4,355) $ (6,040)